MSD Animal Health to Acquire Elanco Animal Health’s Aqua Business For $1.3 Billion
MSD Animal Health, a division of Merck & Co., confirmed on Monday that they have signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated.
Elanco’s aqua business consists of a portfolio of medicines and vaccines, nutrition and supplements for aquatic species, as well as a research facility in Chile and two related aqua manufacturing facilities in Canada and Vietnam. MSD Animal Health says that the acquisition is expected to be completed by mid-year for $1.3 billion in cash...
To Read Full Story Login Below.